PDCL3 expression was found to be significant across multiple cancer types in the TIMER database, including BRCA, CHOL, COAD, ESCA, HNSC, LIHC, LUAD, PRAD, STAD, and UCEC (Fig. 1A). Here, PDCL3 is linked to cancer.